• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.

作者信息

Mitsuhashi Kenjiro, Ishiyama Midori, Imai Yoichi, Shiseki Masayuki, Mori Naoki, Teramura Masanao, Seshimo Akiyoshi, Motoji Toshiko

出版信息

Br J Haematol. 2012 Sep;158(6):798-800. doi: 10.1111/j.1365-2141.2012.09220.x. Epub 2012 Jul 3.

DOI:10.1111/j.1365-2141.2012.09220.x
PMID:22758388
Abstract
摘要

相似文献

1
Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.罗米司亭与静脉注射免疫球蛋白联合治疗可提高血小板计数，有助于一位对单一疗法无反应的难治性免疫性血小板减少症患者进行脾切除术。
Br J Haematol. 2012 Sep;158(6):798-800. doi: 10.1111/j.1365-2141.2012.09220.x. Epub 2012 Jul 3.
2
The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.利妥昔单抗与血小板生成素受体激动剂联合治疗高危难治性免疫性血小板减少症
Blood Transfus. 2015 Oct;13(4):694-5. doi: 10.2450/2015.0325-14. Epub 2015 Apr 21.
3
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.促血小板生成素受体激动剂用于准备接受脾切除术的成人免疫性血小板减少症患者：一项回顾性观察性 GIMEMA 研究的结果。
Am J Hematol. 2016 May;91(5):E293-5. doi: 10.1002/ajh.24341. Epub 2016 Apr 4.
4
Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.新型血小板生成素受体激动剂罗米司亭联合类固醇和免疫球蛋白在难治性免疫性血小板减少症患者脾切除术前用于增加血小板的应用：一例病例报告
Blood Coagul Fibrinolysis. 2012 Jun;23(4):331-4. doi: 10.1097/MBC.0b013e3283513a97.
5
[Trombopag for chronic immune thrombocytopenia in a patient previously treated with romiplostim].[特比澳用于既往接受过罗米司亭治疗的慢性免疫性血小板减少症患者]
Farm Hosp. 2013 May-Jun;37(3):265-6. doi: 10.7399/FH.2013.37.3.548.
6
Idiopathic thrombocytopenic purpura resistant to eltrombopag, but cured with romiplostim.对艾曲泊帕耐药但用罗米司亭治愈的特发性血小板减少性紫癜
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s149-50. doi: 10.2450/2013.0289-12. Epub 2013 Apr 17.
7
[Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital].
Farm Hosp. 2012 Sep-Oct;36(5):434-7. doi: 10.1016/j.farma.2011.08.006. Epub 2012 Aug 4.
8
Romiplostim in chronic immune thrombocytopenic purpura.罗米司亭治疗慢性免疫性血小板减少症。
Clin Ther. 2009 Sep;31(9):1887-907. doi: 10.1016/j.clinthera.2009.09.013.
9
[Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].[一名难治性慢性免疫性血小板减少症儿科患者从艾曲泊帕成功转换为罗米司亭]
Rinsho Ketsueki. 2015 May;56(5):511-3. doi: 10.11406/rinketsu.56.511.
10
[New treatment options for primary immune thrombocytopenia].[原发性免疫性血小板减少症的新治疗选择]
Ugeskr Laeger. 2011 Jan 24;173(4):271-4.

引用本文的文献

1
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.艾曲泊帕在临床实践中用于持续性及新诊断免疫性血小板减少症的疗效与安全性。
Int J Hematol. 2017 Oct;106(4):508-516. doi: 10.1007/s12185-017-2275-4. Epub 2017 Jun 30.
2
Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.罗米司亭在脾切除和未脾切除的免疫性血小板减少症患者中的作用。
Immunotargets Ther. 2016 Feb 22;5:1-7. doi: 10.2147/ITT.S80648. eCollection 2016.
3
Romiplostim as early treatment for refractory primary immune thrombocytopenia.
罗米司亭治疗原发性免疫性血小板减少症的早期治疗。
Int J Hematol. 2013 Nov;98(5):520-4. doi: 10.1007/s12185-013-1439-0. Epub 2013 Sep 26.